Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Biobanking Market Outlook

The global biobanking market size was valued at USD 72.1 billion in 2023, driven by the increased genomic research activities aimed at discovering innovative therapeutic interventions across the globe. The market is expected to grow at a CAGR of 6.89% during the forecast period of 2024-2032, with the values likely to rise from USD 76.9 billion in 2024 to USD 131.1 billion by 2032.

Global Biobanking Market Overview

Biobanks form an essential resource in medical research. They are a type of biorepository to store and manage biological samples. With the growing interest and research on genomics and personalized medicine, the market for biobanks is expected to witness a surge.

The substantial financial support from both private and government sectors is aiding in improving the infrastructure and database capabilities of biobanks. In October 2023 , the United Kingdom Biobank received EUR 16 million, along with another EUR 25 million contribution from the government, to secure a total funding of around EUR 50 million. These investments will aid in the expansion of the biobank’s health data, accelerating research and enabling technological advancements such as the integration of artificial intelligence (AI) to analyze data efficiently. Such financial contributions from public and private organizations will facilitate the biobanking market growth in the forecast period.

The market is also driven by the expansion of the biotechnology sector and the rise in healthcare expenditure to improve patient outcomes. Further, the demand for biobanks is propelled by the rise in the prevalence of chronic diseases and the need for effective treatments.

Global Biobanking Market Trends

Key Trends Description
Increasing Adoption of Precision Medicine The market is witnessing a surge in the adoption of precision medicine approaches, where genetic and molecular information is utilized to customize medical treatments for individual patients. This trend drives the need for biobanking solutions capable to store and manage diverse biological samples.
Emphasis on Data Integration and Standardization With the growing volume and complexity of biological and clinical data, there is an increased emphasis on data integration and standardization within biobanking operations. This ensures data quality and interoperability.
Expansion of Disease-specific Biobanks There is a significant expansion in the establishment of disease-specific biobanks focused on collecting samples from individuals afflicted with certain diseases. These specialized biobanks enable targeted research into disease mechanisms, biomarker discovery, and the development of personalized therapies.
Integration of Advanced Technologies Advanced technologies such as automation, robotics, and artificial intelligence (AI) are increasingly being integrated into biobanking workflows to enhance efficiency, accuracy, and scalability. 

Global Biobanking Market Segmentation

Market Breakup by Material

  • Population-based Biobanks
  • Disease-based Biobanks
  • Academic Biobanks
  • Hospital-based Biobanks
  • Commercial Biobanks

The biobanking market report includes a breakup based on materials as well. It includes population-based biobanks, disease-based biobanks, academic biobanks, hospital-based biobanks, and commercial biobanks. These biobanks serve different purposes such as population-based biobanks collect samples from large groups of individuals for epidemiological and population studies.

Market Breakup by Sample Type

  • Blood Products
  • Human Tissues
  • Nucleic Acids
  • Cell Lines
  • Biological Fluids
  • Others

By sample type, the market is divided into blood products, human tissues, nucleic acids, cell lines, biological fluids, and others. This market segment reveals the range of materials stored in biobanks for research and clinical applications.

Market Breakup by Application

  • Drug Discovery and Development
  • Personalized Medicine
  • Regenerative Medicine
  • Clinical Research
  • Forensics
  • Others

Applications of the market include drug discovery and development, personalized medicine, regenerative medicine, clinical research, forensics, and others. The increased application of biobanks across various sectors has fuelled the biobanking market demand.

Market Breakup by Ownership

  • Public Biobanks
  • Private Biobanks
  • Hybrid Biobanks

The market breakup by ownership in the global biobanking market includes public biobanks, private biobanks, and hybrid biobanks. Public biobanks are operated and funded by governmental or non-profit organizations whereas private biobanks are owned and operated by commercial organizations or individuals. Hybrid biobanks have both public and private ownership structures to collect and manage samples for various purposes.

Market Breakup by Source

  • Human Biobanks
  • Animal Biobanks
  • Plant Biobanks

The market segmentation by source includes human biobanks, animal biobanks, and plant biobanks. This segmentation provides the range of sources utilized in biobanking across different scientific domains.

Market Breakup by End User

  • Biopharmaceutical Companies
  • Research and Academic Institutes
  • Hospitals
  • Contract Research Organizations (CROs)
  • Others

By the end user, the biobanking market share includes biopharmaceutical companies, research and academic institutes, hospitals, contract research organizations (CROs), and others. Biopharmaceutical companies cover a significant portion of the market segment by utilizing biobank samples for drug discovery, development, and clinical trials.

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

The market report will cover the leading regional markets such as North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America holds a high market value, driven by intensive research initiatives, and robust regulatory frameworks. The regional market also has a strong presence of academic and research institutions as well as leading biopharmaceutical companies to support biobanking initiatives.

Global Biobanking Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Thermo Fisher Scientific Inc.
  • Brooks Automation, Inc.
  • Qiagen N.V.
  • Tecan Group Ltd.
  • Hamilton Company
  • Chart Industries, Inc.
  • PHC Holdings Corporation
  • Becton, Dickinson and Company (BD)
  • Merck KGaA
  • Panasonic Healthcare Holdings Co., Ltd.
  • STEMCELL Technologies Inc.
  • Lifenet Health
  • Promega Corporation
  • reiner Bio-One International GmbH
  • Lonza Group AG

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Material
  • Sample Type
  • Application
  • Ownership
  • Source
  • End User
  • Region
Breakup by Material
  • Population-based Biobanks
  • Disease-based Biobanks
  • Academic Biobanks
  • Hospital-based Biobanks
  • Commercial Biobanks
Breakup by Sample Type
  • Blood Products
  • Human Tissues
  • Nucleic Acids
  • Cell Lines
  • Biological Fluids
  • Others
Breakup by Application
  • Drug Discovery and Development
  • Personalized Medicine
  • Regenerative Medicine
  • Clinical Research
  • Forensics
  • Others
Breakup by Ownership
  • Public Biobanks
  • Private Biobanks
  • Hybrid Biobanks
Breakup by Source
  • Human Biobanks
  • Animal Biobanks
  • Plant Biobanks
Breakup by End User
  • Biopharmaceutical Companies
  • Research and Academic Institutes
  • Hospitals
  • Contract Research Organizations (CROs)
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Thermo Fisher Scientific Inc.
  • Brooks Automation, Inc.
  • Qiagen N.V. 
  • Tecan Group Ltd.
  • Hamilton Company
  • Chart Industries, Inc.
  • PHC Holdings Corporation
  • Becton, Dickinson and Company (BD) 
  • Merck KGaA
  • Panasonic Healthcare Holdings Co., Ltd.
  • STEMCELL Technologies Inc.
  • Lifenet Health
  • Promega Corporation
  • Greiner Bio-One International GmbH
  • Lonza Group AG

Key Queries Solved in the Global Biobanking Market Report 

  • How is the market landscape expected to evolve in the forecast period? 
  • What are the major trends influencing the market? 
  • What are the significant drivers, opportunities, and restraints in the market? 
  • What will be the effect of each driver, challenge, and opportunity on the market? 
  • Which regional market is poised to lead the market share in the forecast period? 
  • Which regional market will experience expedited growth during the forecast period? 
  • Which material type of biobanks will fuel market growth? 
  • Which sample type is anticipated to propel the biobanking market value? 
  • Which ownership type of biobanks is expected to dominate the market segment?
  • Which source type will witness high demand in coming years?
  • Which applications are expected to impact the growth of the market significantly?
  • What technological advancements and innovations are influencing the market?
  • Which segment has the highest impact on the market size? 
  • How are partnerships, collaborations, and mergers & acquisitions shaping the market dynamics?

Biobanking Market Report Snapshots

Biobanking Market Size

Biobanking Market Trends

Biobanking Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of about USD 72.1 billion in 2023 driven by the increased genomic research activities aimed at discovering innovative therapeutic interventions across the globe.

The market is anticipated to grow at a CAGR of 6.89% during the forecast period of 2024-2032, likely to reach a market value of USD 131.1 billion by 2032.

Advancements in biobank data analysis such as the integration of artificial intelligence and machine learning are fuelling the market demand. 

One of the significant trends in the market are the rising financial support from both private and government sectors to improve the infrastructure and database capabilities of biobanks. In October 2023, the United Kingdom Biobank received EUR 16 million, coupled with another EUR 25 million contribution from the government. These investments are expected to aid the expansion of biobank’s health data and accelerate research.

Based on the material, the market is segmented into population-based biobanks, disease-based biobanks, academic biobanks, hospital-based biobanks, and commercial biobanks.

By sample type, the market is divided into blood products, human tissues, nucleic acids, cell lines, biological fluids, and others.

The market breakup by ownership in the global biobanking market includes public biobanks, private biobanks, and hybrid biobanks.

The market segmentation by source includes human biobanks, animal biobanks, and plant biobanks. 

Major end users of the market include biopharmaceutical companies, research and academic institutes, hospitals, contract research organizations (CROs), and others.

Applications of the market include drug discovery and development, personalized medicine, regenerative medicine, clinical research, forensics, and others. 

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

Key players involved in the market are Thermo Fisher Scientific Inc., Brooks Automation, Inc., Qiagen N.V., Tecan Group Ltd., Hamilton Company, Chart Industries, Inc., PHC Holdings Corporation, Becton, Dickinson and Company (BD), Merck KGaA, Panasonic Healthcare Holdings Co., Ltd., STEMCELL Technologies Inc., Lifenet Health, Promega Corporation, Greiner Bio-One International GmbH, and Lonza Group AG.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,499

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,599

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,599

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124